Prognostic value of Coronary artery calcium score for the prediction of atherosclerotic cardiovascular disease in participants with suspected nonalcoholic hepatic steatosis: Results from the Multi-Ethnic Study of Atherosclerosis.

[1]  V. Wong,et al.  Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis. , 2023, The lancet. Gastroenterology & hepatology.

[2]  M. Demir,et al.  Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed , 2023, Clinical and molecular hepatology.

[3]  B. Neuschwander‐Tetri,et al.  AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. , 2023, Hepatology.

[4]  M. Budoff,et al.  Performance of the Pooled Cohort Equations in non‐alcoholic fatty liver disease: The Multi‐Ethnic Study of Atherosclerosis , 2022, Liver international : official journal of the International Association for the Study of the Liver.

[5]  Z. Younossi,et al.  Fibrosis-4 Index Can Independently Predict Major Adverse Cardiovascular Events in Nonalcoholic Fatty Liver Disease , 2022, The American journal of gastroenterology.

[6]  J. Ludvigsson,et al.  Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort , 2021, Gut.

[7]  H. Morita,et al.  Incremental prognostic value of non-alcoholic fatty liver disease over coronary computed tomography angiography findings in patients with suspected coronary artery disease. , 2021, European journal of preventive cardiology.

[8]  J. Ludvigsson,et al.  Mortality in Biopsy-Confirmed Nonalcoholic Fatty Liver Disease , 2020, Gut.

[9]  D. Berman,et al.  Comparing Risk Scores in the Prediction of Coronary and Cardiovascular Deaths: Coronary Artery Calcium Consortium. , 2020, JACC. Cardiovascular imaging.

[10]  D. Berman,et al.  All-cause and cause-specific mortality in individuals with zero and minimal coronary artery calcium: A long-term, competing risk analysis in the Coronary Artery Calcium Consortium. , 2019, Atherosclerosis.

[11]  M. Budoff,et al.  Nonalcoholic Fatty Liver Disease Is Associated With Arterial Distensibility and Carotid Intima-Media Thickness: (from the Multi-Ethnic Study of Atherosclerosis). , 2019, The American journal of cardiology.

[12]  Daniel E Forman,et al.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.

[13]  Z. Younossi,et al.  Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients With Nonalcoholic Fatty Liver Disease , 2019, Hepatology communications.

[14]  M. Budoff,et al.  Coronary Calcium Score and Cardiovascular Risk. , 2018, Journal of the American College of Cardiology.

[15]  R. Kronmal,et al.  Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA) , 2018, European heart journal.

[16]  Rohit Loomba,et al.  Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease , 2017, Hepatology.

[17]  Deepak L. Bhatt,et al.  Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry. , 2017, Journal of the American College of Cardiology.

[18]  O. Franco,et al.  Prevalence and Prognostic Implications of Coronary Artery Calcification in Low-Risk Women: A Meta-analysis. , 2016, JAMA.

[19]  J. Lima,et al.  Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study , 2016, Gut.

[20]  Corrado Barbui,et al.  Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. , 2016, Journal of hepatology.

[21]  S. Francque,et al.  Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications. , 2016, Journal of hepatology.

[22]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[23]  R. Kronmal,et al.  Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) , 2016, Circulation.

[24]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[25]  M. Al-mallah,et al.  A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care? , 2013, Atherosclerosis.

[26]  T. Therneau,et al.  Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States , 2013, Hepatology.

[27]  B. Zinman,et al.  Coronary artery calcium score prediction of all cause mortality and cardiovascular events in people with type 2 diabetes: systematic review and meta-analysis , 2013, British medical journal.

[28]  Dong Li,et al.  Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis. , 2012, Academic radiology.

[29]  M. Budoff,et al.  Association between inflammatory markers and liver fat: The Multi-Ethnic Study of Atherosclerosis. , 2012, Journal of clinical & experimental cardiology.

[30]  S. Reeder,et al.  Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy , 2011, Journal of magnetic resonance imaging : JMRI.

[31]  J. J. Rivera,et al.  Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study , 2011, The Lancet.

[32]  Enzo Bonora,et al.  Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. , 2010, The New England journal of medicine.

[33]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[34]  T. Lumley,et al.  Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker , 2000, Biometrics.

[35]  Michael Roden,et al.  NAFLD and diabetes mellitus , 2017, Nature Reviews Gastroenterology &Hepatology.

[36]  R. Detrano,et al.  Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. , 2005, Radiology.